Henri M.H. Spronk

Chief Executive Officer
Coagulation Profile, Maastricht, the Netherlands

Presentation(s):

• OC 17.4 - Effects of andexanet alfa on different thrombin generation and anti-Xa-methods in vitro.

  Sunday, July 10, 2022
  11:30 AM – 11:45 AM

• PB0097 - Serial thrombin generation, while on LMWH prophylaxis in critically ill COVID-19 patients from the prospective MaastrICCht cohort.

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• VPB0372 - Subtype-specific plasma signatures of platelet-related protein releasate in acute pulmonary embolism

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0582 - Elevated contact pathway activity in patients with acute venous thromboembolism

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0870 - Platelet functional phenomics in the post-acute stage of pulmonary embolism

  Monday, July 11, 2022
  6:30 PM – 7:30 PM